Natural Biogenex Approves ₹1.12 Crore Rights Issue

Key Quantitative Figures

Natural Biogenex Private Limited approved a Rights Issue of 11,16,766 Equity Shares. Each share has a face value of ₹10. The issue price is at par (₹10 per share). The total issue size aggregates to ₹1,11,67,660 (Rupees One Crore Eleven Lakh Sixty-Seven Thousand Six Hundred and Sixty only).

Parties Involved

• Issuing Company: Natural Biogenex Private Limited, identified as a 'Material Unlisted Subsidiary'.
• Listed Parent Company: Natural Capsules Limited (Scrip Code: 524654, NSE Symbol: NATCAPSUQ).
• Regulatory Recipients: BSE Limited and National Stock Exchange of India Limited.

Financial Impact

The transaction will result in a cash inflow of ₹1.12 crore for the subsidiary, Natural Biogenex Private Limited. The impact on the capital structure of the subsidiary is an increase in its paid-up share capital by the same amount. The disclosure does not quantify the specific financial impact on the listed parent company, Natural Capsules Limited.

#Tags: #NaturalCapsules #NaturalBiogenex #RightsIssue #SEBIRegulation30 #Fundraising #FinancialUpdate #Neutral